October 15, 2020 By Eric Hausken 2 min read

Across the globe, organizations are using AI to tackle business challenges. Starting today, you can learn how leaders at Cardinal Health, Luxoft and Erie Insurance Group address issues as diverse as overwhelming surges in customer calls to widespread fraud. Register now at no cost to experience conversations between IBM executives and the innovators using AI to strengthen their businesses.

These new sessions are part of our Data and AI Virtual Forums, a series of online and on-demand events geared to help businesses address common challenges on their journey to AI: talent scarcity, data complexity and a lack of trust in AI systems.

Highlights from the on-demand sessions available today:

How Cardinal Health improved their customer experience in the midst of a pandemic

As the COVID-19 pandemic started to spread, global healthcare services company Cardinal Health faced an immediate and overwhelming number of inquiries for medical supplies from organizations across the healthcare sector. To address this influx, Cardinal Health and IBM® quickly built a voice agent powered by Watson® to automate the entire freight inquiry process. And they did it all in just five days. Join and learn how AI can help your organization meet surging customer demand.

How insurers can use AI and cloud platforms to reduce fraud

In this session, executives from Luxoft, Erie Insurance Group and IBM discuss a pervasive industry problem: insurance claims fraud. In the U.S. alone, property and casualty insurance claims fraud tops USD 32 billion every year – and the problem is growing globally. Learn how industry leaders are using AI to improve everything from fraud detection and investigation to triage.

Five trends for modern data governance: a conversation with Forrester

 Before an organization can analyze its data, it needs to navigate complex regulatory, financial, privacy and security requirements. Good data governance means that data can be cataloged, protected and carefully governed across the data pipeline. In this conversation between Forrester and IBM, you can learn about five topics trending around modern data governance. Join to learn how you can strengthen your organization’s governance strategy.

All previous sessions are now available on-demand, and we’ll roll out new sessions throughout October. Check the virtual event site for all available Data and AI Virtual Forum content, including speakers, topics and ways to engage.

Register now and tune into the new sessions.

Was this article helpful?

More from Healthcare

Reducing administrative burden in the healthcare industry with AI and interoperability

6 min read - Every day, tens of thousands of patients in seek care for treatment of new or existing conditions. Behind the scenes, a complex net of information about health records, benefits, coverage, eligibility, authorization and other aspects play a crucial role in the type of medical treatment patients will receive and how much they will have to spend on prescription drugs. This means large amounts of data being produced, stored, and exchanged every second, which is also subject of inefficiencies and gaps…

The synergy between UEM and medical device risk management

5 min read - At the beginning of 2023, according to IBM Security's “Threat Intelligence Index” report, healthcare was in the top 10 most-attacked industries on the planet. The “Cost of a Data Breach 2023” report also uncovered that, since 2020, healthcare data breach costs have increased by 53.3%. Even if it adheres to a lot of regulatory practices, for the 13th year in a row, the healthcare industry reported the most expensive data breaches, at an average cost of USD 10.93 million. 58% of…

Achieve competitive advantage in precision medicine with IBM and Amazon Omics

5 min read - A deeper understanding of biology has the potential to transform how healthcare is delivered, how people are screened, how clinical conditions are treated and monitored. The exponential growth of biomedical datasets over the recent years has resulted in the identification of a great number of molecular signatures vital for the realization of the personalized diagnosis and treatment era. We are at an inflection point, where we have witnessed 100,000-fold reduction in cost since the human genome was first sequenced in…

IBM Newsletters

Get our newsletters and topic updates that deliver the latest thought leadership and insights on emerging trends.
Subscribe now More newsletters